Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study
- 1 February 2003
- Vol. 61 (2) , 338-341
- https://doi.org/10.1016/s0090-4295(02)02123-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancerSurgical Oncology, 2002
- CLINICAL EXPERIENCE WITH 5-AMINOLEVULINIC ACID AND PHOTODYNAMIC THERAPY FOR REFRACTORY SUPERFICIAL BLADDER CANCERJournal of Urology, 2001
- BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)Journal of Urology, 1999
- Early clinical experience with 5‐aminolevulinic acid for the photodynamic therapy of superficial bladder cancerBritish Journal of Urology, 1996
- Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite 1s limited to urothelial cellsUrology, 1994
- Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiationBritish Journal of Dermatology, 1994
- PHOTOCHEMOTHERAPY OF CANCER: EXPERIMENTAL RESEARCHPhotochemistry and Photobiology, 1992
- Photodynamic therapy in patient with xeroderma pigmentosumThe Lancet, 1991
- Photodynamic Therapy with Hematoporphyrin Derivative in the Treatment of Superficial Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1987
- Whole bladder photodynamic therapy for transitional cell carcinoma of bladderUrology, 1985